Pliant Therapeutics Inc. (PLRX) Social Stream



Pliant Therapeutics Inc. (PLRX): $8.53

0.41 (+5.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PLRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

Pliant Therapeutics Inc (PLRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PLRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $63 $45 $52.75 $7.08 645.06%
2021-11-24 5 $63 $38 $49.8 $7.08 603.39%
2022-03-01 6 $63 $38 $48.166 $7.08 580.31%

The Trend in the Analyst Price Target


PLRX's average price target has moved up $4.84 over the prior 20 months.

Over the past 47 weeks, PLRX's average upside potential has been 139.59%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 0 50 40 45.000 35.90 25.35%
2021-04-10 3 52 40 47.330 33.90 39.62%
2021-09-14 5 63 40 51.330 18.80 173.03%
2021-11-03 4 63 45 52.750 17.70 198.02%
2021-12-10 6 63 38 48.166 15.11 218.77%

PLRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 5 1 0 0 0 6

The Trend in the Broker Recommendations


PLRX's average broker recommendation rating improved by 0 over the prior 90 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PLRX as an investment opportunity.

  • In terms of how Pliant Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 389.95% of that group.
  • In the context of stocks in the small market cap category, Pliant Therapeutics Inc's average analyst price target is greater than 355.89% of them.
  • In terms of how Pliant Therapeutics Inc fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 131.7% of that group.
  • In terms of how Pliant Therapeutics Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -161.91% of that group.

In the Pharmaceutical Products industry, PHVS, PHAT, and PHAR are the three stocks most similar to Pliant Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is PLRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4367 seconds.